Home / Insights / New Regulations for Using Gluten-Free Labels

Insight New Regulations for Using Gluten-Free Labels

As of September 4, 2013, the term gluten-free has a new federal definition. In order to bear the label gluten-free, the Food and Drug Administration (FDA) has said that a food must contain less than 20 parts per million of gluten. Gluten is a naturally occurring protein in wheat, rye, and barley grains. A food that is labeled gluten-free, no gluten, free of gluten, or without gluten is misbranded unless it meets the FDA’s new regulation (available here). Beers that are not made from both malted barley and hops, or wines that have less than 7 percent alcohol by volume, are subject to the FDA’s new regulations. Manufactures have a year from September 4, 2013 to comply with the new requirements.

The makers of distilled spirits, wines with 7 percent or more alcohol by volume, and beers that are malt beverages – meaning beers that are made from both malted barley and hops – are not subject to the FDA’s new rule, but must follow the Alcohol and Tobacco Tax and Trade Bureau’s (TTB) interim policy on gluten content statements (available here).

Under the TTB’s interim policy, the term gluten-free is misleading when used to describe a product that is made with any amount of wheat, barley, rye, or any ingredient derived from these grains. For producers of wine or spirits made without any such ingredient, the TTB allows such products to be labeled gluten-free if the producer can verify that it “used good manufacturing practices, took adequate precautions to prevent cross-contamination, and did not use additives, yeast, or storage materials that contained gluten.” The TTB requires very specific disclosures for products produced with gluten, but processed or treated in a manner to remove gluten.

The FDA and TTB gluten-free labeling rules are intended to ensure that consumers, especially those with celiac disease, are provided truthful and accurate information with respect to foods and beverages labeled “gluten free.” If you have questions about the new FDA regulations or the TTB’s interim policy, please contact a member of our Wine, Brew, Spirits Group

Related Insights

Major Immigration Developments Affecting U.S. Employers

Several significant immigration developments have emerged in recent weeks that may affect employers’ hiring practices, workforce planning, immigration sponsorship strategies, and compliance obligations. Most notably,…

Read

Confounding Statutes, How Does Statutory Interpretation Work Again?

This article, originally published in the May 2026 Edition of The Advocate, explores several examples of Idaho statutes where the presence of ambiguities and confusion…

Read

From Hesitation to Implementation: A Practical Guide on Implementing AI into Your Firm

This article, originally published in the May 2026 Edition of The Advocate, explores what law firms can do to leverage AI integration with both innovation…

Read

Reconsidering Medical Liens: Insurance Billing Requirements and Statutory Constraints After DeKlotz

This article, originally published in the May 2026 Edition of The Advocate, examines the Court's interpretation of the Idaho Patient Act (IPA), its articulation of…

Read